Genome-wide association study identifies three loci associated with melanoma risk

Nature Genetics

Volumn 41, Issue 8, 2009, Pages 920-925

  Bishop, D Timothy ^a   Demenais, Florence ^b   Iles, Mark M ^a   Harland, Mark ^a   Taylor, John C ^a   Corda, Eve ^b   Randerson Moor, Juliette ^a   Aitken, Joanne F ^c   Avril, Marie Francoise ^d   Azizi, Esther ^e   Bakker, Bert ^f   Bianchi Scarr, Giovanna ^g   Bressac De Paillerets, Brigitte ^h   Calista, Donato ⁱ   Cannon Albright, Lisa A ^j   Chin A Woeng, Thomas ^k   Dbniak, Tadeusz ^l   Galore Haskel, Gilli ^e   Ghiorzo, Paola ^g   Gut, Ivo ^m   Hansson, Johan ⁿ   Hočevar, Marko ^o   Höiom, Veronica ⁿ   Hopper, John L ^p   Ingvar, Christian ^q   Kanetsky, Peter A ^r   Kefford, Richard F ^s   Landi, Maria Teresa ^t   Lang, Julie ^u   Lubiski, Jan ^l   MacKie, Rona ^u   Malvehy, Josep ^v,w   Mann, Graham J ^s   Martin, Nicholas G ^x   Montgomery, Grant W ^x   Van Nieuwpoort, Frans A ^f   Novakovic, Srdjan ^o   Olsson, Håkan ^q   Puig, Susana ^v,w   Weiss, Marjan ^f   Van Workum, Wilbert ^k   Zelenika, Diana ^m   Brown, Kevin M ^y   Goldstein, Alisa M ^t   Gillanders, Elizabeth M ^z   Boland, Anne ^m   Galan, Pilar ^aa   Elder, David E ^r   Gruis, Nelleke A ^f   Hayward, Nicholas K ^x   Lathrop, G Mark ^b,m   Barrett, Jennifer H ^a   Newton Bishop, Julia A ^a   more..

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^d Cancer Council ^*  (France)

^e TEL AVIV UNIVERSITY   (Israel)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF GENOA   (Italy)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ BUFALINI HOSPITAL   (Italy)

^j UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^k ServiceXS   (Netherlands)

^l POMERANIAN MEDICAL UNIVERSITY   (Poland)

^m CENTRE NATIONAL DE GÉNOTYPAGE   (France)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

^o INSTITUTE OF ONCOLOGY   (Slovenia)

^p UNIVERSITY OF MELBOURNE   (Australia)

^q LUND UNIVERSITY HOSPITAL   (Sweden)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s UNIVERSITY OF SYDNEY   (Australia)

^t NATIONAL INSTITUTES OF HEALTH   (United States)

^u UNIVERSITY OF GLASGOW   (United Kingdom)

^v HOSPITAL CLÍNIC   (Spain)

^w CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^x QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^y TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^z NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^aa Translational Genomics Research Institute ^*  (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; AUSTRALIA; CANCER RISK; CASE CONTROL STUDY; CHROMOSOME 9P; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FAMILY HISTORY; GENE LOCUS; GENETIC ASSOCIATION; GENOME; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN PIGMENTATION;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GEOGRAPHY; HUMANS; MELANOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS;

EID: 68149179663     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.411     Document Type: Article

References (42)

1. Cannon-Albright, L.A., Bishop, D.T., Goldgar, C. & Skolnick, M.H. Genetic predisposition to cancer. in Important Advances in Oncology (eds. DeVita, V.T., Hellman, S. & Rosenberg, S.A.) 39-55 (J. B. Lippincott & Co., Philadelphia, 1991).
2. Bataille, V. et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br. J. Cancer 73, 1605-1611 (1996).
3. Chang, Y.M. et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int. J. Cancer 124, 420-428 (2009).
4. Hollenbeak, C.S. et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 104, 1962-1967 (2005).
5. Naldi, L. et al. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann. Epidemiol. 15, 545-550 (2005).
6. Titus-Ernstoff, L. et al. Pigmentary characteristics and moles in relation to melanoma risk. Int. J. Cancer 116, 144-149 (2005).
7. Holly, E.A., Aston, D.A., Cress, R.D., Ahn, D.K. & Kristiansen, J.J. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am. J. Epidemiol. 141, 923-933 (1995).
8. Holly, E.A., Aston, D.A., Cress, R.D., Ahn, D.K. & Kristiansen, J.J. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am. J. Epidemiol. 141, 934-942 (1995).
9. Raimondi, S. et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int. J. Cancer 122, 2753-2760 (2008).
10. Kanetsky, P.A. et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 66, 9330-9337 (2006).
11. Gudbjartsson, D.F. et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886-891 (2008).
12. Elwood, J.M. & Jopson, J. Melanoma and sun exposure: an overview of published studies. Int. J. Cancer 73, 198-203 (1997).
13. Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8, 23-26 (1994).
14. Berwick, M. et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol. Biomarkers Prev. 15, 1520-1525 (2006).
15. Goldstein, A.M. et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J. Med. Genet. 44, 99-106 (2007).
16. Bishop, J.A. et al. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J. Invest. Dermatol. 114, 28-33 (2000).
17. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
18. Novembre, J. et al. Genes mirror geography within Europe. Nature 456, 98-101 (2008).
19. Han, J. et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 4, e1000074 (2008).
20. Pasmant, E. et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963-3969 (2007).
21. Brown, K.M. et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat. Genet. 40, 838-840 (2008).
22. Falchi, M et al. Genome-wide association study identifies loci at 9p21 and 22q13 associated with development of cutaneous nevi. Nat. Genet. advance online publication, doi:10.1038/ng.410 (5 July 2009).
23. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
24. Antoniou, A.C. & Easton, D.F. Polygenic inheritance of breast cancer: implications for design of association studies. Genet. Epidemiol. 25, 190-202 (2003).
25. Puig, S. et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J. Clin. Oncol. 23, 3043-3051 (2005).
26. Baxter, A.J. et al. The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures. Twin Res. Hum. Genet. 11, 183-196 (2008).
27. Whiteman, D.C. et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 57, 173-180 (2008).
28. Landi, M.T. et al. Genetic susceptibility in familial melanoma from northeastern Italy. J. Med. Genet. 41, 557-566 (2004).
29. Pastorino, L. et al. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pigment Cell Melanoma Res. 21, 700-709 (2008).
30. Newton Bishop, J.A. et al. Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br. J. Cancer 80, 295-300 (1999).
31. Borg, A. et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J. Natl. Cancer Inst. 92, 1260-1266 (2000).
32. Chaudru, V. et al. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J. Natl. Cancer Inst. 96, 785-795 (2004).
33. Platz, A. et al. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J. Natl. Cancer Inst. 89, 697-702 (1997).
34. Holland, E.A. et al. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 11, 2289-2294 (1995).
35. Holland, E.A., Schmid, H., Kefford, R.F. & Mann, G.J. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosom. Cancer 25, 339-348 (1999).
36. Debniak, T. et al. Common variants of DNA repair genes and malignant melanoma. Eur. J. Cancer 44, 110-114 (2008).
37. Peric, B. et al. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families. BMC Med. Genet. 9, 86 (2008).
38. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
39. Patterson, N., Price, A.L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
40. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
41. Clayton, D. Testing for association on the X chromosome. Biostatistics 9, 593-600 (2008).
42. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007).